» Articles » PMID: 33631340

COVID-19 Sequelae in Adults Aged Less Than 50 Years: A Systematic Review

Overview
Date 2021 Feb 25
PMID 33631340
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is emerging evidence of long-term sequelae in a considerable proportion of COVID-19 patients after recovery and the spectrum and severity of such sequelae should be systematically reviewed. This review aims to evaluate the available evidence of all intermediate and long-term COVID-19 sequelae affecting formerly healthy adults.

Methods: A systematic literature search of Embase, WHO, Scopus, Pubmed, Litcovid, bioRxiv and medRxiv was conducted with a cutoff date of the 17th September 2020 according to PRISMA guidelines and registered in PROSPERO (CRD42020208725). Search terms included "COVID-19", "coronavirus disease 2019", "SARS-CoV-2", "sequelae" and "consequence*". Publications on adult participants, with a confirmed SARS-CoV-2 infection were included. Elderly (>50 years old) and children (<18 years old) were excluded. Bias assessment was performed using a modified Newcastle-Ottawa Scale.

Results: A total of 31 papers were included. Study types included prospective and retrospective cohort studies, cross-sectional studies and case reports. Sequelae persistence since infection spanned 14 days to three months. Sequelae included persistent fatigue (39-73% of assessed persons), breathlessness (39-74%), decrease in quality of life (44-69%), impaired pulmonary function, abnormal CT findings including pulmonary fibrosis (39-83%), evidence of peri-/perimyo-/myocarditis (3-26%), changes in microstructural and functional brain integrity with persistent neurological symptoms (55%), increased incidence of psychiatric diagnoses (5.8% versus 2.5-3.4% in controls), incomplete recovery of olfactory and gustatory dysfunction (33-36% of evaluated persons).

Conclusions: A variety of organ systems are affected by COVID-19 in the intermediate and longer-term after recovery. Main sequelae include post-infectious fatigue, persistent reduced lung function and carditis. Careful follow-up post COVID 19 is indicated to assess and mitigate possible organ damage and preserve life quality.

Citing Articles

Coronavirus Disease 2019 Case Series in China: Sequelae and Effectiveness of Vaccination and Antiviral Drugs.

Ren M Infect Drug Resist. 2025; 18:1125-1133.

PMID: 40027918 PMC: 11871847. DOI: 10.2147/IDR.S499058.


Fu Tu Sheng Jin Rehabilitation Formula Mitigate Airway Inflammation, Mucus Secretion and Immune Dysfunction Induced by SARS-CoV-2 Spike Protein.

Wang B, Yu K, Zhang X, Sun X, Tang L, Shi X J Inflamm Res. 2025; 18:1053-1065.

PMID: 39871960 PMC: 11771161. DOI: 10.2147/JIR.S480112.


SARS-COV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential workers in New York: a retrospective cohort study.

Babalola T, Clouston S, Sekendiz Z, Chowdhury D, Soriolo N, Kawuki J Lancet Reg Health Am. 2025; 42:100984.

PMID: 39866362 PMC: 11764319. DOI: 10.1016/j.lana.2024.100984.


Orexin-A increases the differentiation of human olfactory sensory neurons through orexin receptor type 1.

Chen Y, Young T, Wang Y, Huang C, Gao Y, Huang T Regen Ther. 2024; 26:1058-1068.

PMID: 39582799 PMC: 11585478. DOI: 10.1016/j.reth.2024.10.014.


Evaluating the Predictors of Persistent Long COVID Symptoms and Their Severity in COVID-19 Survivors 1 Year After Infection.

Aldhawyan A, A BuSaad M, Alamri B, Alsaihati M, Alanazi B, Alanazi R J Prim Care Community Health. 2024; 15():21501319241295686.

PMID: 39471195 PMC: 11528748. DOI: 10.1177/21501319241295686.


References
1.
Hollingshead C, Hanrahan J . Spontaneous Pneumothorax Following COVID-19 Pneumonia. IDCases. 2020; 21:e00868. PMC: 7306487. DOI: 10.1016/j.idcr.2020.e00868. View

2.
Frija-Masson J, Debray M, Gilbert M, Lescure F, Travert F, Borie R . Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J. 2020; 56(2). PMC: 7301832. DOI: 10.1183/13993003.01754-2020. View

3.
Chary E, Carsuzaa F, Trijolet J, Capitaine A, Roncato-Saberan M, Fouet K . Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study. Am J Rhinol Allergy. 2020; 34(5):686-693. PMC: 7418272. DOI: 10.1177/1945892420930954. View

4.
Rogers J, Chesney E, Oliver D, Pollak T, McGuire P, Fusar-Poli P . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020; 7(7):611-627. PMC: 7234781. DOI: 10.1016/S2215-0366(20)30203-0. View

5.
Mazza M, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I . Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020; 89:594-600. PMC: 7390748. DOI: 10.1016/j.bbi.2020.07.037. View